- Retraction Note
- Open Access
Retraction Note: IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 24 (2023)
Retraction Note: J Exp Clin Cancer Res 39, 190 (2020)
The Editor in Chief and all authors have retracted this article. After publication, concerns were raised about the following issues with the images:
Fig. 1C: the tumour-IHC:IMP3 panel appears very similar to the tumour-SAT1 panel in Fig 2N in a paper by different authors that was under submission at the same time .
Fig. 2B: the LNCap IMP3 blot appears very similar to the SK-KEP-1 ACSL4 blot in Fig 2B in a previously-published paper by different authors .
Fig. 2F contains multiple panels that seem to overlap with panels in Fig 1C a previously-published paper by different authors , Fig 1D in a previously-published paper by different authors , as well as Fig 5E, 6E and 7H in a paper by different authors that was under submission at the same time .
Fig. 4A: the SMURF1 blot appears very similar to the N-Cahedrin blot in a paper by different authors that was under submission at the same time .
Fig. 6F contains two tumours that appear similar to those in Figs 2M and 7H in in a previously-published paper by different authors .
The authors supplied the raw data, but in view of the multiple nature of the overlaps, the Editor in Chief has lost confidence in the integrity of the results of the article. All authors agree with this retraction.
Xiao Y, Li C, Wang H, Liu Y. LINC00265 targets miR-382-5p to regulate SAT1, VAV3 and angiogenesis in osteosarcoma. Aging. 2020;12(20):20212–25. https://doi.org/10.18632/aging.103762.
Wang J, Wang Z, Yuan J, Wang J, Shen X. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma. Aging. 2020;12(9):1945–4589. https://doi.org/10.18632/aging.103092.
Sun L, Jiang C, Xu C, Xue H, Zhou H, Gu L, et al. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway. Oncotarget **. 2017;8:27929–42. https://doi.org/10.18632/oncotarget.15846.
Hu XM, Xiang JJ, Xiao BL, Huang YF, Xie JP. Wogonoside promotes apoptosis in gastric cancer AGS and SGC-7901 cells through induction of mitochondrial dysfunction and endoplasmic reticulum stress. FEBS Open Bio. 2019;9(8):1469–76. https://doi.org/10.1002/2211-5463.12693.
Ghosh Choudhury G, Chen Y, Zhang W, Shen L, Kadier A, Huang J, et al. Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p. Biomed Res Int. 2020:2314–6133. https://doi.org/10.1155/2020/4817608.
Yang J, Yu L, Yan J, Xiao Y, Li W, Xiao J, et al. Circular RNA DGKB promotes the progression of neuroblastoma by targeting miR-873/GLI1 Axis. Front Oncol. 2020;10:1104. https://doi.org/10.3389/fonc.2020.01104.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, X., Wang, D., Liu, B. et al. Retraction Note: IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way. J Exp Clin Cancer Res 42, 24 (2023). https://doi.org/10.1186/s13046-023-02599-z